These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8832764)

  • 1. The inhibitory effects of non-prostanoid prostacyclin mimetics on rat neutrophil function.
    Wise H
    Prostaglandins Leukot Essent Fatty Acids; 1996 May; 54(5):351-60. PubMed ID: 8832764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.
    Chow KB; Wong YH; Wise H
    Br J Pharmacol; 2001 Dec; 134(7):1375-84. PubMed ID: 11724742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of prostacyclin mimetics on neutrophil function.
    Wise H
    Adv Exp Med Biol; 1997; 407():261-4. PubMed ID: 9321962
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of prostacyclin mimetics distinguishes neuronal from neutrophil IP receptors.
    Wise H; Qian YM; Jones RL
    Eur J Pharmacol; 1995 May; 278(3):265-9. PubMed ID: 7589166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
    Jones RL; Qian YM; Wise H; Wong HN; Lam WL; Chan HW; Yim AP; Ho JK
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding.
    Seiler SM; Brassard CL; Federici ME; Romine J; Meanwell NA
    Prostaglandins; 1997 Jan; 53(1):21-35. PubMed ID: 9068064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of prostanoid receptors on rat neutrophils.
    Wise H; Jones RL
    Br J Pharmacol; 1994 Oct; 113(2):581-7. PubMed ID: 7834211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-prostanoid prostacyclin mimetics as neuronal stimulants in the rat: comparison of vagus nerve and NANC innervation of the colon.
    Rudd JA; Qian Ym; Tsui KK; Jones RL
    Br J Pharmacol; 2000 Feb; 129(4):782-90. PubMed ID: 10683203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of non-prostanoid prostacyclin mimetics on cyclic AMP production by neuronal SK-N-SH cells.
    Wise H; Chow KB
    Adv Exp Med Biol; 1997; 433():197-200. PubMed ID: 9561134
    [No Abstract]   [Full Text] [Related]  

  • 10. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting prostacyclin receptor agonist efficacy in different cell types.
    Kam Y; Chow KB; Wise H
    Cell Signal; 2001 Nov; 13(11):841-7. PubMed ID: 11583920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the prostaglandin EP4-receptor subtype is highly coupled to inhibition of N-formyl-methionyl-leucyl-phenylalanine-stimulated rat neutrophil aggregation.
    Wise H
    Prostaglandins Leukot Essent Fatty Acids; 1998 Jan; 58(1):77-84. PubMed ID: 9482170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
    Armstrong RA
    Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of prostaglandin E2 on rat neutrophil aggregation.
    Wise H
    J Leukoc Biol; 1996 Oct; 60(4):480-6. PubMed ID: 8864132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-[3-[2-(4,5-Diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): a new, structurally-novel prostacyclin partial agonist: 1). Inhibition of platelet aggregation and mechanism of action.
    Seiler SM; Brassard CL; Federici ME; Buchanan JO; Zavoico GB; Fleming JS; Meanwell NA
    Thromb Res; 1994 Apr; 74(2):115-23. PubMed ID: 8029812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prostacyclin analogs on cyclic adenosine monophosphate and superoxide formation in human polymorphonuclear leukocytes stimulated by formyl-methionyl-leucyl-phenylalanine.
    Stahlberg HJ; Loschen G; Flohé L
    Biol Chem Hoppe Seyler; 1988 May; 369(5):329-36. PubMed ID: 2844208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
    Merritt JE; Brown AM; Bund S; Cooper DG; Egan JW; Hallam TJ; Heagerty AM; Hickey DM; Kaumann AJ; Keen M
    Br J Pharmacol; 1991 Jan; 102(1):260-6. PubMed ID: 2043927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of prostacyclin and prostaglandin E(2) receptor mediated responses in adult rat dorsal root ganglion cells, in vitro.
    Rowlands DK; Kao C; Wise H
    Br J Pharmacol; 2001 May; 133(1):13-22. PubMed ID: 11325789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182.
    Darius H; Michael-Hepp J; Thierauch KH; Fisch A
    Eur J Pharmacol; 1994 Jun; 258(3):207-13. PubMed ID: 7522176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.